Brooktree Capital Management Eli Lilly & CO Transaction History

Brooktree Capital Management

$120 Million
Q3 2024

A detailed history of Brooktree Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Brooktree Capital Management holds 4,206 shares of LLY stock, worth $3.15 Million. This represents 3.09% of its overall portfolio holdings.

Number of Shares

4,206

Previous 4,624 9.04%

Holding current value

$3.15 Million

Previous $4.19 Million 10.99%

% of portfolio

3.09%

Previous 3.62%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$772.14 - $960.02 $322,754 - $401,288	-418 Reduced 9.04%	4,206 $3.73 Million
Q2 2024 Aug 05, 2024	SELL	$724.87 - $909.04 $875,642 - $1.1 Million	-1,208 Reduced 20.71%	4,624 $4.19 Million
Q1 2024 May 06, 2024	SELL	$592.2 - $792.28 $744,395 - $995,895	-1,257 Reduced 17.73%	5,832 $4.54 Million
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $46,741 - $55,102	-89 Reduced 1.24%	7,089 $4.13 Million
Q3 2023 Nov 06, 2023	SELL	$434.7 - $599.3 $215,611 - $297,252	-496 Reduced 6.46%	7,178 $3.86 Million
Q2 2023 Aug 08, 2023	SELL	$350.74 - $468.98 $203,078 - $271,539	-579 Reduced 7.02%	7,674 $3.6 Million
Q1 2023 May 08, 2023	SELL	$310.63 - $364.82 $205,326 - $241,146	-661 Reduced 7.42%	8,253 $2.83 Million
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $126,596 - $144,270	-427 Reduced 4.57%	8,914 $2.88 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $61,041 - $71,672	-219 Reduced 2.29%	9,341 $3.03 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $558,327 - $693,859	-2,379 Reduced 19.93%	9,560 $2.74 Million
Q4 2021 Feb 07, 2022	SELL	$224.85 - $279.04 $236,991 - $294,108	-1,054 Reduced 8.11%	11,939 $3.3 Million
Q3 2021 Nov 09, 2021	SELL	$221.6 - $272.71 $83,321 - $102,538	-376 Reduced 2.81%	12,993 $3 Million
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $3,611 - $4,670	-20 Reduced 0.15%	13,369 $3.07 Million
Q1 2021 May 03, 2021	SELL	$164.32 - $212.72 $23,004 - $29,780	-140 Reduced 1.03%	13,389 $2.5 Million
Q4 2020 Feb 03, 2021	SELL	$130.46 - $172.63 $109,195 - $144,491	-837 Reduced 5.83%	13,529 $2.28 Million
Q3 2020 Nov 09, 2020	SELL	$146.22 - $169.13 $32,168 - $37,208	-220 Reduced 1.51%	14,366 $2.13 Million
Q2 2020 Aug 03, 2020	SELL	$136.42 - $164.18 $12,687 - $15,268	-93 Reduced 0.63%	14,586 $2.39 Million
Q4 2019 Feb 26, 2020	BUY	$106.92 - $132.43 $1.57 Million - $1.94 Million	14,679 New	14,679 $1.93 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brooktree Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brooktree Capital Management with notifications on news.

Account

Brooktree Capital Management Eli Lilly & CO Transaction History